Metraipolis › archive › dc_e01a6f2c72be

Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade — Europe PMC PMID:42776834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42776834
DOI
10.3390/hematolrep18050068
License (as archived)
solo-consultazione
Archived
2026-10-08T02:27:58.456Z
SHA-256 of the archived text
03e673bcab7199f0be11f66505236967bbd882f82bc43a23799a44c55a7d4b77
Stable URL of this page
https://metraipolis.com/documento/dc_e01a6f2c72be

How to cite

Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade — Europe PMC PMID:42776834 — Europe PMC (en), https://europepmc.org/article/MED/42776834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e01a6f2c72be (Metraipolis archive dc_e01a6f2c72be, sha256 03e673bcab7199f0be11f66505236967bbd882f82bc43a23799a44c55a7d4b77)
BibTeX
@misc{dce01a6f2c72be,
  title = {Lung-Predominant Hyperinflammatory Syndrome in Therapy-Related Myelodysplastic Syndrome Responsive to Interleukin-1 Blockade — Europe PMC PMID:42776834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42776834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e01a6f2c72be; sha256 03e673bcab7199f0be11f66505236967bbd882f82bc43a23799a44c55a7d4b77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42776834. Agents can read the archived copy with the MCP tool read_document.